Literature DB >> 31866424

Human Cytomegalovirus miRNAs Regulate TGF-β to Mediate Myelosuppression while Maintaining Viral Latency in CD34+ Hematopoietic Progenitor Cells.

Meaghan H Hancock1, Lindsey B Crawford1, Andrew H Pham1, Jennifer Mitchell1, Hillary M Struthers1, Andrew D Yurochko2, Patrizia Caposio1, Jay A Nelson3.   

Abstract

Infection with human cytomegalovirus (HCMV) remains a significant cause of morbidity and mortality following hematopoietic stem cell transplant (HSCT) because of various hematologic problems, including myelosuppression. Here, we demonstrate that latently expressed HCMV miR-US5-2 downregulates the transcriptional repressor NGFI-A binding protein (NAB1) to induce myelosuppression of uninfected CD34+ hematopoietic progenitor cells (HPCs) through an increase in TGF-β production. Infection of HPCs with an HCMVΔmiR-US5-2 mutant resulted in decreased TGF-β expression and restoration of myelopoiesis. In contrast, we show that infected HPCs are refractory to TGF-β signaling as another HCMV miRNA, miR-UL22A, downregulates SMAD3, which is required for maintenance of latency. Our data suggest that latently expressed viral miRNAs manipulate stem cell homeostasis by inducing secretion of TGF-β while protecting infected HPCs from TGF-β-mediated effects on viral latency and reactivation. These observations provide a mechanism through which HCMV induces global myelosuppression following HSCT while maintaining lifelong infection in myeloid lineage cells.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD34(+) hematopoietic progenitor cells; NAB1; SMAD3; TGF-β; hematopoiesis; human cytomegalovirus; latency; miRNAs; myelosuppression

Mesh:

Substances:

Year:  2019        PMID: 31866424      PMCID: PMC6952548          DOI: 10.1016/j.chom.2019.11.013

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  68 in total

1.  Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.

Authors:  Naoki Mori; Mariko Morishita; Tomoo Tsukazaki; Naoki Yamamoto
Journal:  Int J Cancer       Date:  2003-07-10       Impact factor: 7.396

2.  The transcription factor Krox20 is an E3 ligase that sumoylates its Nab coregulators.

Authors:  Pablo García-Gutiérrez; Francisco Juárez-Vicente; Francisco Gallardo-Chamizo; Patrick Charnay; Mario García-Domínguez
Journal:  EMBO Rep       Date:  2011-09-30       Impact factor: 8.807

3.  Hematopoietic long-term culture (hLTC) for human cytomegalovirus latency and reactivation.

Authors:  Mahadevaiah Umashankar; Felicia Goodrum
Journal:  Methods Mol Biol       Date:  2014

4.  Kaposi's sarcoma-associated herpesvirus downregulates transforming growth factor β2 to promote enhanced stability of capillary-like tube formation.

Authors:  Terri A DiMaio; Kimberley D Gutierrez; Michael Lagunoff
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

5.  Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.

Authors:  Salem Akel; Cari Petrow-Sadowski; Mary J Laughlin; Francis W Ruscetti
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

6.  Cytomegalovirus and marrow function.

Authors:  B Torok-Storb; P Simmons; D Khaira; D Stachel; D Myerson
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

7.  A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences.

Authors:  B A Christy; L F Lau; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Epstein-Barr virus antagonizes the antiproliferative activity of transforming growth factor-beta but does not abolish its signaling.

Authors:  Manuela Horndasch; Eva E Raschke; Guido Bommer; Marino Schuhmacher; Elisabeth Dumont; Conny Kuklik-Roos; Dirk Eick; Bettina Kempkes
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

9.  Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway.

Authors:  Igor Landais; Chantel Pelton; Daniel Streblow; Victor DeFilippis; Shannon McWeeney; Jay A Nelson
Journal:  PLoS Pathog       Date:  2015-05-08       Impact factor: 6.823

10.  Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.

Authors:  Hong Seok Choi; Vaibhav Jain; Brian Krueger; Vickie Marshall; Chang Hee Kim; Joanna L Shisler; Denise Whitby; Rolf Renne
Journal:  PLoS Pathog       Date:  2015-11-06       Impact factor: 6.823

View more
  21 in total

Review 1.  Human Cytomegalovirus Induced Aberrant Expression of Non-coding RNAs.

Authors:  Zhongjie Yu; Jing Wang; Fulong Nan; Wenyi Shi; Xianjuan Zhang; Shasha Jiang; Bin Wang
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

Review 2.  MicroRNA Regulation of Human Herpesvirus Latency.

Authors:  Siyu Chen; Yue Deng; Dongli Pan
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

Review 3.  Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.

Authors:  Byeong-Jae Lee; Chan-Ki Min; Meaghan Hancock; Daniel N Streblow; Patrizia Caposio; Felicia D Goodrum; Andrew D Yurochko
Journal:  Front Microbiol       Date:  2021-05-07       Impact factor: 5.640

4.  Human Cytomegalovirus Latency and Myelosuppression: A microRNA-Dependent Yin and Yang Regulatory Loop.

Authors:  Lauren Gay; Rolf Renne
Journal:  Cell Host Microbe       Date:  2020-01-08       Impact factor: 31.316

5.  CD34+ Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.

Authors:  Lindsey B Crawford; Meaghan H Hancock; Hillary M Struthers; Daniel N Streblow; Andrew D Yurochko; Patrizia Caposio; Felicia D Goodrum; Jay A Nelson
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

6.  A BMPR2/YY1 Signaling Axis Is Required for Human Cytomegalovirus Latency in Undifferentiated Myeloid Cells.

Authors:  Emma Poole; Maria Cristina Carlan da Silva; Chris Huang; Marianne Perera; Sarah Jackson; Ian J Groves; Mark Wills; Amer Rana; John Sinclair
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

7.  Human Cytomegalovirus Infection Suppresses CD34+ Progenitor Cell Engraftment in Humanized Mice.

Authors:  Lindsey B Crawford; Rebecca Tempel; Daniel N Streblow; Andrew D Yurochko; Felicia D Goodrum; Jay A Nelson; Patrizia Caposio
Journal:  Microorganisms       Date:  2020-04-06

Review 8.  The Differentiation of Human Cytomegalovirus Infected-Monocytes Is Required for Viral Replication.

Authors:  Chan-Ki Min; Akhalesh K Shakya; Byeong-Jae Lee; Daniel N Streblow; Patrizia Caposio; Andrew D Yurochko
Journal:  Front Cell Infect Microbiol       Date:  2020-07-31       Impact factor: 5.293

9.  Human Cytomegalovirus miR-US5-2 Downregulation of GAB1 Regulates Cellular Proliferation and UL138 Expression through Modulation of Epidermal Growth Factor Receptor Signaling Pathways.

Authors:  Meaghan H Hancock; Jennifer Mitchell; Felicia D Goodrum; Jay A Nelson
Journal:  mSphere       Date:  2020-08-05       Impact factor: 4.389

Review 10.  Common Sources of Inflammation and Their Impact on Hematopoietic Stem Cell Biology.

Authors:  Daniel Hormaechea-Agulla; Duy T Le; Katherine Y King
Journal:  Curr Stem Cell Rep       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.